Merrimack Pharmaceuticals (NASDAQ:MACK) Cut to "Sell" at Sto

StockNews.com cut shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) from a hold rating to a sell rating in a research report released on Monday morning. Merrimack Pharmaceuticals Trading Up 0.1 % Merrimack Pharmaceuticals stock opened at $15.13 on Monday. The firm has a market capitalization of $219.84 million, a P/E ratio of -189.13 and […]

Related Keywords

Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , , Wittenberg Investment Management Inc , Kennedy Capital Management , Merrimack Pharmaceuticals Trading , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Aristides Capital , Merrimack Pharmaceuticals Increases Dividend , Merrimack Pharmaceuticals , News Ratings For Merrimack Pharmaceuticals Daily , Free Report , Get Free Report , Financial Markets , Capital Management , Investment Management , Merrimack Pharmaceuticals Daily ,